CLOs on the Move

Tethys Bioscience

www.tethysbio.com

 
Tethys Bioscience is a personalized predictive medicine company developing novel tests which address the growing global healthcare challenge of chronic diseases such as diabetes.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.tethysbio.com
  • 5858 Horton St Ste 550
    Emeryville, CA USA 94608
  • Phone: 510.420.6700

Executives

Name Title Contact Details

Similar Companies

ICU Medical Inc.

ICU Medical, Inc. is engaged in the development, manufacture and sale of disposable medical connection systems for use in vascular therapy applications.

Brahms USA

Brahms USA, LLC is a Annapolis, MD-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

PickPoint Corporation

PickPoint Corporation is a Pleasanton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Value Behavioral Health of Pennsylvania

Value Behavioral Health of Pennsylvania is a Trafford, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alternate Health

Alternate Health (CSE: AHG, OTCQB: AHGIF) an international leader in the hemp-derived CBD industry, including extraction, product development and distribution. Alternate Health`s industry-leading software systems provide the platform for the company`s diverse operations, including blockchain tax collection systems, hemp-derived CBD product distribution, extract manufacturing and patient management systems for specialty clinics across North America. Through Alternate Health`s subsidiary, Blaine Labs, the Company is a leader in cGMP medical product manufacturing and distribution, with over 50 product SKUs available from major retailers, including Walmart, Amazon, CVS and Walgreens. Alternate Health`s corporate office is located in Toronto, Canada, with additional offices in Venice, California, and San Antonio, Texas. The Company is well positioned to reinvest internal operating cash flow in its platform and product development over the long term, creating an attractive investment profile for its shareholders.